BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37311434)

  • 1. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.
    Liu YC; Geyer JT
    Pathobiology; 2024; 91(1):30-44. PubMed ID: 37311434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
    Gao J; Gong S; Chen YH
    Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
    Obiorah IE; Upadhyaya KD; Calvo KR
    Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
    Kanagal-Shamanna R; Schafernak KT; Calvo KR
    Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
    Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
    Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular findings in myeloid neoplasms.
    Tran TB; Siddon AJ
    Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition in acute leukaemia.
    Wiggins M; Stevenson W
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():75-81. PubMed ID: 32115888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
    Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
    Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndromes].
    Strullu M; Leblanc T; Lainey E
    Bull Cancer; 2023 Nov; 110(11):1183-1195. PubMed ID: 37453833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
    Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
    BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
    Czuchlewski DR; Peterson LC
    Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic predisposition to pediatric myeloid malignancies].
    Muramatsu H
    Rinsho Ketsueki; 2016 Jun; 57(6):730-5. PubMed ID: 27384852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Myelodysplastic Syndrome.
    Chisholm KM; Bohling SD
    Clin Lab Med; 2023 Dec; 43(4):639-655. PubMed ID: 37865508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in research of the pathogenesis of childhood MDS/MPN].
    Yoshida K
    Rinsho Ketsueki; 2018; 59(10):2284-2289. PubMed ID: 30305537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.